New ‘metamaterial’ can make MRI scans safer and cheaper

Boston University researchers have developed a new “metamaterial” they hope can make MRI scans more efficient and cost-friendly.

The technology is made up of copper wiring and plastic and costs less than $10. When placed under the scanner next to a patient’s body part, the material can increase the signal-to-noise ratio, producing a clearer image.

Not only can the metamaterial boost signal-to-noise ratio 10-fold, but It can reduce scan times, potentially making the modality more widely available for patients at lower costs.

"Shortening MRI examinations is paramount to maximizing the capacity," Stephan Anderson, a Boston Medical Center radiologist and BU School of Medicine professor of radiology, said in a statement. “Not to mention revenue, as well as the overall patient experience of this powerful imaging technology."

Anderson and other team members describe the material as “intelligent” in that it amplifies the typically low-energy emissions from a patient’s body and shuts itself down during the short, high-energy bursts emitted by the MRI machine. Although those bursts last only milliseconds, that is enough to enhance the reflected energy from a patient and reduce their exposure to radiation.

"We can now build smart materials that can interact with radio waves intelligently, enhancing the wanted signal while letting the unwanted signal go," said Xin Zhang, a BU College of Engineering professor.

The new material, described in the journal Advanced Materials, is currently a flat, thick-layer prototype, but the researchers plan to augment it into a flexible, super thin MRI sheet, they said.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup